ganaxolone 50 MG in 1 mL Oral Suspension
- RxCUI
- 2604694
- RxNorm name
- ganaxolone 50 MG in 1 mL Oral Suspension
- Display name
- ganaxolone 50 MG in 1 mL Oral Suspension
- Full name
- ganaxolone 50 MG in 1 mL Oral Suspension
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:23
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ZTALMY | GANAXOLONE | Immedica Pharma US Inc | d91612c4-b03a-4be4-a1ee-6a13e3b83d4e | 2025-11-28 | Warnings, Adverse reactions | 2604694 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| d91612c4-b03a-4be4-a1ee-6a13e3b83d4e | ganaxolone 50 MG in 1 mL Oral Suspension | PSN | 13 | These highlights do not include all the information needed to use ZTALMY ® safely and effectively. See full prescribing information for ZTALMY. ZTALMY ® (ganaxolone) oral suspension, CV Initial U.S. Approval: 2022 | 20251128 |
| d91612c4-b03a-4be4-a1ee-6a13e3b83d4e | ganaxolone 50 MG per 1 ML Oral Suspension | SY | 13 | These highlights do not include all the information needed to use ZTALMY ® safely and effectively. See full prescribing information for ZTALMY. ZTALMY ® (ganaxolone) oral suspension, CV Initial U.S. Approval: 2022 | 20251128 |
| d91612c4-b03a-4be4-a1ee-6a13e3b83d4e | ganaxolone 50 MG/ML Oral Suspension | SCD | 13 | These highlights do not include all the information needed to use ZTALMY ® safely and effectively. See full prescribing information for ZTALMY. ZTALMY ® (ganaxolone) oral suspension, CV Initial U.S. Approval: 2022 | 20251128 |